Metal-based complexes have demonstrated significant anticancer effects and have emerged
as candidates with great potential for cancer therapy. These agents are effective in a variety …

Conclusion We very much appreciated working with all the authors noted above on
assembling this special issue and we hope that you enjoy reading their excellent …

Metal-based anticancer drugs are among the most successful therapeutic agents, as
evidenced by the frequent prescription of selected platinum and arsenic compounds to …

Cancer remains a leading cause of death worldwide. Despite breakthrough clinical
therapies for the treatment of cancer using platinum and arsenic compounds, metal …

Cancer is characterized by abnormal cell differentiation in or on the part of the body. The
most commonly used chemotherapeutic drugs are developed to target rapidly dividing cells …

In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …

Metal complexes have been the subject of numerous investigations in oncology but, despite
the plethora of newly synthesized compounds, their precise mechanisms of action remain …

Metal complexes in cancer therapy have attracted much interest mainly because metals
exhibit unique characteristics, such as redox activity, metal‐ligand interaction, structure and …

Metal-based coordination compounds have been used throughout the history of human
medicine to treat various diseases, including cancer. Since the discovery of cisplatin in …

Guest editors Enzo Alessio and Zijian Guo present an overview of the topics reported in the
papers of this issue, listing the general trends that dominate the field of metal anticancer …